Scholarlink

Background <p>Phenotype disruption of lung resident mesenchymal stem cells (MSC) is a key event in the pathogenesis of bronchopulmonary dysplasia (BPD). Hyperoxia (HOX) constitutes one major harmful factor resulting in growth arrest and changes of functional properties including downregulation of PDGFRα. FGF-10, HGF, IGF-1 and PDGF-AA constitute promising cytokines to preserve lung growth. We studied their preventive application before HOX exposure of MSC cultures.</p> Results <p>As described before, HOX inhibited spontaneous proliferation of MSC and induced cell death. Growth inhibition was larger at HOX80% than at HOX40%. The one-time preventive application of FGF-10, HGF, IGF-1 or PDGF-AA in therapeutic dosage or the repetitive application during HOX (40% or 80%) did not attenuate the growth inhibition and cell death induction by HOX even during the milder HOX40% exposure. Furthermore, the phenotype disruption with downregulation of PDGFRα as critical hallmark event remained unchanged.</p> Conclusion <p>Our data indicate that the deleterious effects of HOX to lung resident MSC are that pronounced that single lung growth promoting cytokines cannot attenuate their phenotype disruption, growth inhibition and cell death by HOX. The results demand focus on MSC functionality when the therapeutic potential of lung growth promoting factors and other therapeutics intended to prevent BPD is studied.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Preventive application of lung growth factors and lack of attenuation of phenotype disruption of lung resident MSC from preterm infants by hyperoxia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月22日

查看全文
  • Lena Holzfurtner,
  • Judith Behnke,
  • Pauline Korte,
  • Maurizio J. Goetz,
  • Jutta Petzinger,
  • Anita C. Windhorst,
  • Tayyab Shahzad,
  • Stefano Rivetti,
  • Ying Dong,
  • Saverio Bellusci,
  • Harald Ehrhardt

摘要

Background

Phenotype disruption of lung resident mesenchymal stem cells (MSC) is a key event in the pathogenesis of bronchopulmonary dysplasia (BPD). Hyperoxia (HOX) constitutes one major harmful factor resulting in growth arrest and changes of functional properties including downregulation of PDGFRα. FGF-10, HGF, IGF-1 and PDGF-AA constitute promising cytokines to preserve lung growth. We studied their preventive application before HOX exposure of MSC cultures.

Results

As described before, HOX inhibited spontaneous proliferation of MSC and induced cell death. Growth inhibition was larger at HOX80% than at HOX40%. The one-time preventive application of FGF-10, HGF, IGF-1 or PDGF-AA in therapeutic dosage or the repetitive application during HOX (40% or 80%) did not attenuate the growth inhibition and cell death induction by HOX even during the milder HOX40% exposure. Furthermore, the phenotype disruption with downregulation of PDGFRα as critical hallmark event remained unchanged.

Conclusion

Our data indicate that the deleterious effects of HOX to lung resident MSC are that pronounced that single lung growth promoting cytokines cannot attenuate their phenotype disruption, growth inhibition and cell death by HOX. The results demand focus on MSC functionality when the therapeutic potential of lung growth promoting factors and other therapeutics intended to prevent BPD is studied.